GI
MRNA icon

GAMCO Investors’s Moderna MRNA Stock Holding History

GAMCO Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,000
Closed -$762K – 924
2021
Q4 		$762K Sell
3,000
-3,000
-50% -$877K 0.01% 673
2021
Q3 		$2.31M Hold
6,000
– – 0.02% 484
2021
Q2 		$1.41M Buy
6,000
+1,000
+20% +$179K 0.01% 581
2021
Q1 		$655K Buy
+5,000
New +$725K 0.01% 710
2020
Q4 		– Sell
-5,140
Closed -$364K – 898
2020
Q3 		$364K Hold
5,140
– – ﹤0.01% 730
2020
Q2 		$330K Buy
+5,140
New +$281K ﹤0.01% 728

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAMCO Investors's MRNA Position: Q1 2022 in Review

GAMCO Investors sold out of Moderna (MRNA) in Q1 2022, closing a stake of 3,000 shares — an estimated $762K sold.

GAMCO Investors first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $2.31M in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • GAMCO Investors reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • GAMCO Investors sold 3,000 Moderna shares in Q1 2022, an estimated $762K.
  • GAMCO Investors first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • GAMCO Investors's Moderna position peaked at $2.31M in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on GAMCO Investors's 13F filing for Q1 2022, filed 13 May 2022.